Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomabOliver W Press, Joseph M Unger, Lisa M Rimsza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.Journal of the National Cancer Institute|May 15, 2023
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancerEleftherios P Mamounas, Hanna Bandos, Priya Rastogi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trialEdith A Perez, Vera J Suman, Nancy E Davidson, et al.Clinical Breast Cancer|December 24, 2022
Clinical Utility of Genomic Recurrence Risk Stratification in Early, Hormone-Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Real-World ExperienceKhalil Choucair, Seth J Page, Bassam I Mattar, et al.JAMA Oncology|December 17, 2020
Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With CancerCatherine H Van Poznak, Joseph M Unger, Amy K Darke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 6, 2020
Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105Dawn L Hershman, Joseph M Unger, Grace Clarke Hillyer, et al.British Journal of Haematology|November 19, 2014
REVEAL-1, a phase 2 dose regimen optimization study of vosaroxin in older poor-risk patients with previously untreated acute myeloid leukaemiaRobert K Stuart, Larry D Cripe, Michael B Maris, et al.Mayo Clinic Proceedings|February 13, 2007
Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse preventionIvana T Croghan, Richard D Hurt, Shaker R Dakhil, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2008
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27Priya Rastogi, Stewart J Anderson, Harry D Bear, et al.Pageof 12